Literature DB >> 15716273

Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis.

Onikepe Adegbola1, Gary R Pasternack.   

Abstract

The retinoblastoma gene product (Rb) is a tumor suppressor that affects apoptosis paradoxically. Most sporadic cancers inactivate Rb by preferentially targeting the pathway that regulates Rb phosphorylation, resulting in resistance to apoptosis; this contrasts with Rb inactivation by mutation, which is associated with high rates of apoptosis. How phosphorylated Rb protects cells from apoptosis is not well understood, but there is evidence that Rb may sequester a pro-apoptotic nuclear factor. pp32 (ANP32A) is a pro-apoptotic nuclear phosphoprotein, the expression of which is commonly increased in cancer. We report that hyperphosphorylated Rb interacts with pp32 but not with the closely related proteins pp32r1 and pp32r2. We further demonstrate that pp32-Rb interaction inhibits the apoptotic activity of pp32 and stimulates proliferation. These results suggest a mechanism whereby cancer cells gain both a proliferative and survival advantage when Rb is inactivated by hyperphosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716273     DOI: 10.1074/jbc.M411382200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.

Authors:  Patrick T Reilly; Samia Afzal; Chiara Gorrini; Koren Lui; Yury V Bukhman; Andrew Wakeham; Jillian Haight; Teo Wei Ling; Carol C Cheung; Andrew J Elia; Patricia V Turner; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

2.  Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.

Authors:  Patrick T Reilly; Yun Yu; Ali Hamiche; Lishun Wang
Journal:  Bioessays       Date:  2014-08-25       Impact factor: 4.345

3.  Concordant expression pattern across multiple immune tissues of commercial broilers in response to avian pathogenic Escherichia coli (APEC).

Authors:  Hongyan Sun; Huan Li
Journal:  3 Biotech       Date:  2019-08-05       Impact factor: 2.406

4.  RB goes mitochondrial.

Authors:  Laura D Attardi; Julien Sage
Journal:  Genes Dev       Date:  2013-05-01       Impact factor: 11.361

Review 5.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule.

Authors:  D W Goodrich
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

6.  Overexpression of the pp32r1 (ANP32C) oncogene or its functional mutant pp32r1Y140H confers enhanced resistance to FTY720 (Finguimod).

Authors:  Salma Buddaseth; Wiebke Göttmann; Rainer Blasczyk; Trevor Huyton
Journal:  Cancer Biol Ther       Date:  2013-12-12       Impact factor: 4.742

7.  Generation and characterization of the Anp32e-deficient mouse.

Authors:  Patrick T Reilly; Samia Afzal; Andrew Wakeham; Jillian Haight; Annick You-Ten; Kathrin Zaugg; Joanna Dembowy; Ashley Young; Tak W Mak
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 8.  The RB/E2F pathway and regulation of RNA processing.

Authors:  Joseph Ahlander; Giovanni Bosco
Journal:  Biochem Biophys Res Commun       Date:  2009-05-03       Impact factor: 3.575

9.  The crystal structure of the tumor suppressor protein pp32 (Anp32a): structural insights into Anp32 family of proteins.

Authors:  Trevor Huyton; Cynthia Wolberger
Journal:  Protein Sci       Date:  2007-06-13       Impact factor: 6.725

Review 10.  The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.

Authors:  Zbyslaw Sondka; Sally Bamford; Charlotte G Cole; Sari A Ward; Ian Dunham; Simon A Forbes
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.